Hepatitis C-Diabetes associated w-advanced fibrosis and progression in HCV non-genotype 3 patients

Hepatitis C-Diabetes associated w-advanced fibrosis and progression in HCV non-genotype 3 patients - Hallo friend NEWS AN INSPIRATION, In the article you read this time with the title Hepatitis C-Diabetes associated w-advanced fibrosis and progression in HCV non-genotype 3 patients, we have prepared well for this article you read and download the information therein. hopefully fill posts Article ECONOMY, Article HEALTH, Article POLITICS, Article SPORTS, Article TRAVELING, Article UPDATE, we write can understand. Well, happy reading.

Titre : Hepatitis C-Diabetes associated w-advanced fibrosis and progression in HCV non-genotype 3 patients
link : Hepatitis C-Diabetes associated w-advanced fibrosis and progression in HCV non-genotype 3 patients

Read also


Hepatitis C-Diabetes associated w-advanced fibrosis and progression in HCV non-genotype 3 patients

In case you missed it

Dig Liver Dis. 2018 Jul 17. pii: S1590-8658(18)30814-4. doi: 10.1016/j.dld.2018.07.003. 
[Epub ahead of print]

Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients.

Researchers investigated if diabetes is associated with progression from the non-cirrhotic liver to cirrhosis in non-genotype 3 chronic hepatitis C (CHC) patients. In the study 976 non-genotype 3 patients with HCV were studied, out of the 976 participants, 684 did not have cirrhosis. According to ultrasound findings, 60 patients developed cirrhosis during the follow-up period. In non-genotype 3 CHC patients, diabetes was correlated with progression from the non-cirrhotic liver to cirrhosis.

Abstract
BACKGROUND:
Diabetes is a risk factor of fibrosis progression in chronic hepatitis C (CHC). However, only one longitudinal study exploring whether diabetes is associated with progression from non-cirrhotic liver to cirrhosis in CHC patients has been conducted.

AIMS: 
We investigated whether diabetes is associated with progression from non-cirrhotic liver to cirrhosis in non-genotype 3 CHC patients.

METHODS: 
A cohort consisting of 976 non-genotype 3 patients histologically proven to have CHC was studied. After excluding patients with biopsy-proven or ultrasound-identified cirrhosis, there were 684 patients without cirrhosis. All 684 patients underwent hepatocellular carcinoma surveillance using ultrasound every 6 months, with a median duration of follow-up evaluation of 102.4 months. During the follow-up period, 60 patients developed cirrhosis according to ultrasound findings.

RESULTS: 
For the subgroup of 684 patients without cirrhosis, Kaplan-Meier survival analyses showed no significantly different cumulative incidences of cirrhosis (log-rank test; P = 0.71) among the patients with diabetes as compared to those without. However, after making adjustments for age, gender, fibrosis, steatosis, sustained virological response status, and obesity using Cox's proportional hazard model, diabetes was found to be an independent predictor for cirrhosis (HR = 1.9; 95% CI = 1.05-3.43, P = 0.03).

CONCLUSIONS: 
Diabetes is associated with progression from non-cirrhotic liver to cirrhosis in non-genotype 3 CHC patients.

KEYWORDS:
Diabetes; Genotype 3; Hepatitis C virus; Liver cirrhosis; Ultrasound
PMID: 30076015 DOI: 10.1016/j.dld.2018.07.003 
Full text article requires payment 


Thus articles Hepatitis C-Diabetes associated w-advanced fibrosis and progression in HCV non-genotype 3 patients

that is all articles Hepatitis C-Diabetes associated w-advanced fibrosis and progression in HCV non-genotype 3 patients This time, hopefully can provide benefits to you all. Okay, see you in another article post.

You are now reading the article Hepatitis C-Diabetes associated w-advanced fibrosis and progression in HCV non-genotype 3 patients the link address https://newsaninpiration.blogspot.com/2018/08/hepatitis-c-diabetes-associated-w.html

Subscribe to receive free email updates:

0 Response to "Hepatitis C-Diabetes associated w-advanced fibrosis and progression in HCV non-genotype 3 patients"

Post a Comment